CERO THERAPEUTICS HOLDINGS, INC. (CERO) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value |
| Current obligations | 32.41M USD | Liabilities, Current |
| Cash and equivalents | 862.76K USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $32.41M | $862.76K | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $11.33M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $9.09M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $8.45M | $1.90M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $7.62M | $3.20M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $7.86M | $5.10M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $7.40M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $9.42M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $8.78M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $11.65M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $5.17M | $96.87K | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $4.80M | $119.01K | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $4.41M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $3.29M | $178.09K | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $30.75M | $475.87K | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $875.97K | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $234.21K | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $174.66K | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $98.07K | $1.10M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $277.00K | $0.00 | (m) | (m) | (m) | (m) |
| 2021-06-07 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |